Phase II trial of homoharringtonine with imatinib in chronic, accelerated, and blast phase chronic myeloid leukemia

Abhishek Maiti, Jorge Cortes, Alessandra Ferrajoli, Zeev Estrov, Gautam Borthakur, Guillermo Garcia-Manero, Elias Jabbour, Farhad Ravandi, Susan O’Brien, Hagop Kantarjian

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)2240-2242
Number of pages3
JournalLeukemia and Lymphoma
Volume58
Issue number9
DOIs
StatePublished - Sep 2 2017

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Phase II trial of homoharringtonine with imatinib in chronic, accelerated, and blast phase chronic myeloid leukemia. / Maiti, Abhishek; Cortes, Jorge; Ferrajoli, Alessandra; Estrov, Zeev; Borthakur, Gautam; Garcia-Manero, Guillermo; Jabbour, Elias; Ravandi, Farhad; O’Brien, Susan; Kantarjian, Hagop.

In: Leukemia and Lymphoma, Vol. 58, No. 9, 02.09.2017, p. 2240-2242.

Research output: Contribution to journalLetter

Maiti, A, Cortes, J, Ferrajoli, A, Estrov, Z, Borthakur, G, Garcia-Manero, G, Jabbour, E, Ravandi, F, O’Brien, S & Kantarjian, H 2017, 'Phase II trial of homoharringtonine with imatinib in chronic, accelerated, and blast phase chronic myeloid leukemia', Leukemia and Lymphoma, vol. 58, no. 9, pp. 2240-2242. https://doi.org/10.1080/10428194.2017.1283030
Maiti, Abhishek ; Cortes, Jorge ; Ferrajoli, Alessandra ; Estrov, Zeev ; Borthakur, Gautam ; Garcia-Manero, Guillermo ; Jabbour, Elias ; Ravandi, Farhad ; O’Brien, Susan ; Kantarjian, Hagop. / Phase II trial of homoharringtonine with imatinib in chronic, accelerated, and blast phase chronic myeloid leukemia. In: Leukemia and Lymphoma. 2017 ; Vol. 58, No. 9. pp. 2240-2242.
@article{6f5c0aec612c4ebcb2a53d28a128b77d,
title = "Phase II trial of homoharringtonine with imatinib in chronic, accelerated, and blast phase chronic myeloid leukemia",
author = "Abhishek Maiti and Jorge Cortes and Alessandra Ferrajoli and Zeev Estrov and Gautam Borthakur and Guillermo Garcia-Manero and Elias Jabbour and Farhad Ravandi and Susan O’Brien and Hagop Kantarjian",
year = "2017",
month = "9",
day = "2",
doi = "10.1080/10428194.2017.1283030",
language = "English (US)",
volume = "58",
pages = "2240--2242",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - Phase II trial of homoharringtonine with imatinib in chronic, accelerated, and blast phase chronic myeloid leukemia

AU - Maiti, Abhishek

AU - Cortes, Jorge

AU - Ferrajoli, Alessandra

AU - Estrov, Zeev

AU - Borthakur, Gautam

AU - Garcia-Manero, Guillermo

AU - Jabbour, Elias

AU - Ravandi, Farhad

AU - O’Brien, Susan

AU - Kantarjian, Hagop

PY - 2017/9/2

Y1 - 2017/9/2

UR - http://www.scopus.com/inward/record.url?scp=85011900723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011900723&partnerID=8YFLogxK

U2 - 10.1080/10428194.2017.1283030

DO - 10.1080/10428194.2017.1283030

M3 - Letter

C2 - 28278723

AN - SCOPUS:85011900723

VL - 58

SP - 2240

EP - 2242

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 9

ER -